Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects

NCT02416674 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT02416674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02416674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
March 1, 2015
Completion date
February 28, 2025
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal wall defect